Bektas M, Copley-Merriman C, Khan S, Sarda SP, Shammo JM. Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs. J Manag Care Spec Pharm. 2020 Dec;26(12-b Suppl):S14-20. doi: 10.18553/jmcp.2020.26.12-b.s14
Bektas M, Copley-Merriman C, Khan S, Sarda SP, Shammo JM. Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease. J Manag Care Spec Pharm. 2020 Dec;26(12-b Suppl):S8-S14. doi: 10.18553/jmcp.2020.26.12-b.s8
Bektas M, Copley-Merriman C, Khan S, Sarda SP, Shammo JM. Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology. J Manag Care Spec Pharm. 2020 Dec;26(12-b Suppl):S3-8. doi: 10.18553/jmcp.2020.26.12-b.s3
Patterson BJ, Herring WL, van Oorschot D, Curran D, Carrico J, Zhang Y, Ackerson BK, Bruxvoort K, Sy LS, Tseng HF. Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model. J Manag Care Spec Pharm. 2020 Dec;26(12):1567-75. doi: 10.18553/jmcp.2020.20251
Serbin M, Odak S, Macahilig C, Joshi N, Shah A, Ng X, Olson K, Liang GS, Klepitskaya O, Yonan C. Burden of parkinson's disease in a real-world sample of patients with motor fluctuations. Poster presented at the 2020 Virtual AMCP NEXUS; October 2020. [abstract] J Manag Care Spec Pharm. 2020 Oct; 26(10-a):S43. doi: 10.18553/jmcp.2020.26.10-a.s1
Jiang S, Varghese D, Appukkuttan S, Corman S, Kebede N, Gnanasakthy K, Macahilig C, Waldeck R, Hussain A. Real-world incidence and management of adverse events (AEs) in patients with non-metastatic castrate-resistant prostate cancer receiving apalutamide or enzalutamide. Poster presented at the Virtual Journal of Managed Care & Specialty Pharmacy 2020 Conference; October 2020. [abstract] J Manag Care Spec Pharm. 2020 Oct; 26(10-a Suppl):S89. Previously presented at the 2020 Virtual ISPOR Asia Pacific Conference.
Bhattacharya R, Herren K, Poonawalla I, Bunniran S, Bloomfield A, Schwab PE. Comparing medical utilization and cost outcomes in oral versus injectable immunotherapy users with chronic inflammatory joint and skin diseases. J Manag Care Spec Pharm. 2020 Oct;26(10):1246-56. doi: 10.18553/jmcp.2020.26.10.1246